BridgeMD
Clinical trial on the virucidal activity of different oral antiseptics against respiratory viruses.
EU CTIS ID: 2024-515939-30-01
What this study is testing
In patients diagnosed with COVID19, influenza A or RSV, analyze the immediate viricidal activity in saliva against these three respiratory viruses from a single rinse of different oral antiseptics, as well as the duration of this effect up to 7 hours after application.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Present a diagnosis of infection by these respiratory viruses.
- Less than 5 days have passed since the appearance of the clinical symptoms typical of each viral infection.
- Not receiving any type of antiviral treatment.
- Be over 16 years old.
You likely can't join if
- Pregnant.
- Present a history of allergy to the antiseptics evaluated.
- Simultaneous therapy with lithium, presence of hyperthyroidism, goiter, thyroid nodules, or other acute and non-acute thyroid diseases, before or after radioactive iodine scintigraphy or treatment of thyroid carcinoma with radioactive iodine, practice of tests with tolvidin or guaiacol, to determine hemoglobin or glucose in feces or urine.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.